Could a shorter pill course tame chagas in young women?

NCT ID NCT03672487

Completed Disease control Sponsor: Tulane University School of Public Health and Tropical Medicine Source: ClinicalTrials.gov ↗

First seen Apr 09, 2026 · Last updated May 21, 2026 · Updated 5 times

Summary

This study tested whether a shorter, lower-dose course of benznidazole (30 days, 150 mg/day) works as well as the standard 60-day, higher-dose treatment for reducing the parasite that causes Chagas disease. The participants were women who had recently given birth and had Chagas but had not been treated before. The goal was to see if the shorter treatment could lower the amount of parasite in the blood just as effectively, with fewer side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHAGAS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Institute for Clinical Effectiveness and Health Policy

Buenos Aires, Argentina
Tulane School of Public Health and Tropical Medicine

New Orleans, Louisiana, 70112, United States
University of California at San Diego

San Diego, California, 92093, United States

Conditions

Explore the condition pages connected to this study.

CHAGAS DISEASE